摘要
目的:探讨无抽搐电休克治疗仪联合药物治疗精神分裂症的疗效。方法:选择118例精神分裂症患者,随机分为两组各59例,对照组单用药物治疗,研究组在其基础上使用无抽搐电休克治疗仪治疗。治疗前后分别采取阳性症状与阴性症状量表(PANSS)和可重复的成套神经心理状态测验(RBANS)对患者进行评估。结果:治疗后,研究组阳性症状为(16.42±3.15)分,阴性症状为(24.47±4.52)分,一般精神病理为(23.20±3.14)分,明显低于对照组(19.18±3.52)分,(28.10±4.50)分,(28.11±3.63)分,比较具有明显差异(P<0.05)。研究组RBANS评分为(127.40±23.47)分,对照组为(127.18±25.63)分,比较无明显差异(P>0.05)。结论:联用无抽搐电休克治疗仪能够改善精神分裂症的症状,并对认知功能无明显影响。
Objective:To explore the curative effect of non-convulsive electric shock therapy device combined with drugs in the treatment of schizophrenia.Methods:118 patients with schizophrenia were selected and randomly divided into two groups with 59 cases in each group.The control group was treated with drugs alone,and the study group was treated with a non-convulsive electric shock therapy device on the basis of this.The Positive and Negative Symptom Scale(PANSS)and the Repeatable Neuropsychological State Test(RBANS)were used to evaluate the patients before and after treatment.Results:After treatment,the positive symptoms of the study group were(16.42±3.15)points,the negative symptoms were(24.47±4.52)points,and the general psychopathology was(23.20±3.14)points,which was significantly lower than the control group(19.18±3.52)points,(28.10±4.50)points,(28.11±3.63)points,there is a significant difference(P<0.05).The RBANS score of the study group was(127.40±23.47)points,and the control group was(127.18±25.63)points,and there was no significant difference(P>0.05).Conclusion:The combined use of non-convulsive electric shock therapy device can improve the symptoms of schizophrenia,and has no obvious impact on cognitive function.
作者
赵鹏
ZHAO Peng(Dandong Third Hospital,Liaoning Dandong 118000)
出处
《中国医疗器械信息》
2020年第16期158-159,共2页
China Medical Device Information
关键词
无抽搐电休克治疗仪
精神分裂症
临床疗效
non-convulsive electric shock therapy device
schizophrenia
clinical efficacy